cerebral arteriovenous malformation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. BAVM patients; 2. Aged >= 13 and <= 60 years; 3. The informed consent is signed by the patient himself or his legal guardian or representative.
Exclusion criteria
Exclusion criteria: 1. AVM has a history of embolization, radiation therapy or partial resection. 2. MRS >= 3 points due to intracranial hemorrhage or neurological dysfunction before treatment; 3. Radiologically confirmed complicated with ruptured aneurysm; 4. AVM is too diffuse;Platelet count 1.4, or TP or ATPP increased; 5. Any irreversible clotting disorder or known clotting disorder; 6. Patients requiring long-term anticoagulation; 7. Premenopausal women with positive urine or plasma pregnancy tests (no recorded history of surgical sterilization); 8. Major concomitant diseases such as liver, kidney, gastrointestinal, respiratory, cardiovascular, endocrine, immune and hematological diseases that are subject to imaging safety assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immediate embolization rate after the last endovascular treatment;The vascular malformation occlusion rate was followed up 2 years after operation.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cerebral hemorrhage and ischemic events within one week after the end of the last embolization were included;Intracerebral hemorrhage during clinical follow-up from 1 week after the last embolization to 2 years;MRS scores were obtained during the last clinical follow-up 2 years after surgery; | — |
Countries
China
Contacts
The PLA Naval Medical University